Skip to content

PURA VIDA INVESTMENTS, LLC

Follow

13F filer, CIK 1590144, NEW YORK, NY

PURA VIDA INVESTMENTS, LLC reported holdings worth $36,993,272 (the sum of its rows) across 19 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13. The total stated on the cover page is $16,515,697. Its ten largest share positions make up 92.42% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001590144-26-000004

The cover page states a total of $16,515,697, 55% less than the sum of the rows, $36,993,272. This page uses the sum of the rows.

Period
2026-06-30
Value, sum of rows
$37M
Stated on the cover page
$16.5M
Holdings
19
Top 10 weight
92.42%
New
2
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ALMRnew+755,909$20.5M
KOnew+2,500$203K
MSFTadded+10$3.73K
GOOGadded+10$3.53K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
IMDXreduced-462,289-$2.73M
CAIreduced-64,440-$1.15M
NTRAreduced-1,000-$271K
NVDAreduced-200-$40K
BBNXreduced-86-$1.35K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001590144-26-000004, largest first. % of portfolio is the value over $36,993,272, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ALMRALAMAR BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 755,909 shares 755,909$20.5M55.35%newTimeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 429,120 shares; 2025Q2: 2,500 shares; 2025Q3: 281,250 shares; 2025Q4: 281,250 shares; 2026Q1: 281,250 shares; 2026Q2: 281,164 shares 281,164$4.41M11.91%-86Timeline
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 191,939 shares; 2024Q4: 113,041 shares; 2025Q1: 45,000 shares; 2025Q2: 89,940 shares; 2025Q3: 45,000 shares; 2025Q4: 45,000 shares; 2026Q1: 45,000 shares; 2026Q2: 45,000 shares 45,000$3.86M10.44%0Timeline
IMDXINSIGHT MOLECULAR DIA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 495,345 shares; 2024Q4: 654,451 shares; 2025Q1: 947,134 shares; 2025Q2: 18,700 shares; 2025Q3: 947,134 shares; 2025Q4: 947,134 shares; 2026Q1: 947,134 shares; 2026Q2: 484,845 shares 484,845$2.86M7.73%-462,289Timeline
NVDANVIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,330 shares; 2026Q1: 2,500 shares; 2026Q2: 2,300 shares 2,300$460K1.24%-200Timeline
CAICARIS LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 45,000 shares; 2025Q3: 89,940 shares; 2025Q4: 89,940 shares; 2026Q1: 89,940 shares; 2026Q2: 25,500 shares 25,500$454K1.23%-64,440Timeline
JPMJPMORGAN CHASE & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,350 shares; 2026Q1: 1,350 shares; 2026Q2: 1,350 shares 1,350$442K1.19%0Timeline
GOOGALPHABET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,190 shares; 2026Q1: 1,190 shares; 2026Q2: 1,200 shares 1,200$424K1.15%+10Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 43,500 shares; 2024Q4: 5,000 shares; 2025Q1: 2,500 shares; 2025Q2: 245,691 shares; 2025Q3: 2,500 shares; 2025Q4: 2,500 shares; 2026Q1: 2,500 shares; 2026Q2: 1,500 shares 1,500$407K1.1%-1,000Timeline
ADIANALOG DEVICES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,000 shares; 2026Q1: 1,000 shares; 2026Q2: 1,000 shares 1,000$397K1.07%0Timeline
ASMLASML HLDG NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 190 shares; 2026Q1: 190 shares; 2026Q2: 190 shares 190$378K1.02%0Timeline
MSFTMICROSOFT CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,200 shares; 2026Q1: 990 shares; 2026Q2: 1,000 shares 1,000$373K1.01%+10Timeline
OMOUTSET MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 5,000 shares; 2025Q2: 429,120 shares; 2025Q3: 5,000 shares; 2025Q4: 5,000 shares; 2026Q1: 83,333 shares; 2026Q2: 83,333 shares 83,333$360K0.97%0Timeline
AAPLAPPLE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,165 shares; 2026Q1: 1,165 shares; 2026Q2: 1,165 shares 1,165$337K0.91%0Timeline
NSPRINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 450,517 shares; 2024Q4: 450,517 shares; 2025Q1: 450,517 shares; 2025Q2: 450,517 shares; 2025Q3: 450,517 shares; 2025Q4: 450,517 shares; 2026Q1: 450,517 shares; 2026Q2: 450,517 shares 450,517$315K0.85%0Timeline
MGXMETAGENOMI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 270,618 shares; 2024Q4: 264,391 shares; 2025Q1: 264,391 shares; 2025Q2: 952,134 shares; 2025Q3: 264,391 shares; 2025Q4: 264,391 shares; 2026Q1: 264,391 shares; 2026Q2: 264,391 shares 264,391$315K0.85%0Timeline
AMZNAMAZON COM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,000 shares; 2026Q1: 1,100 shares; 2026Q2: 1,100 shares 1,100$262K0.71%0Timeline
LINLINDE PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 500 shares; 2026Q1: 500 shares; 2026Q2: 500 shares 500$259K0.7%0Timeline
KOCOCA COLA COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,500 shares 2,500$203K0.55%newTimeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001590144-26-000004 base2026-08-13acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001590144-26-000004 Quarter ended 2026-06-302026-08-13acceptance time not in the bulk data set
13F-HR 0001590144-26-000003 Quarter ended 2026-03-312026-05-12acceptance time not in the bulk data set
13F-HR 0001590144-26-000002 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0001590144-25-000009 Quarter ended 2025-09-302025-11-12acceptance time not in the bulk data set
13F-HR 0001590144-25-000006 Quarter ended 2025-06-302025-08-13acceptance time not in the bulk data set
13F-HR 0001590144-25-000003 Quarter ended 2025-03-312025-05-12acceptance time not in the bulk data set
13F-HR 0001590144-25-000002 Quarter ended 2024-12-312025-02-12acceptance time not in the bulk data set
13F-HR 0001590144-24-000023 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001590144-24-000021 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001590144-24-000019 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001590144-24-000002 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-HR 0001590144-23-000030 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001590144-23-000028 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001590144-23-000026 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001590144-23-000008 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001590144-22-000027 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001590144-22-000023 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001590144-22-000021 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001590144-22-000008 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001590144-21-000021 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001696778-21-000003 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001493152-21-011115 Quarter ended 2021-03-312021-05-12acceptance time not in the bulk data set
13F-HR 0001493152-21-003932 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR/A 0001493152-21-003553 Quarter ended 2019-12-312021-02-12acceptance time not in the bulk data set
13F-HR/A 0001493152-21-003541 Quarter ended 2020-03-312021-02-12acceptance time not in the bulk data set
13F-HR/A 0001493152-21-003538 Quarter ended 2019-03-312021-02-12acceptance time not in the bulk data set
13F-HR/A 0001493152-21-003551 Quarter ended 2019-09-302021-02-12acceptance time not in the bulk data set
13F-HR/A 0001493152-21-003545 Quarter ended 2019-06-302021-02-12acceptance time not in the bulk data set
13F-HR/A 0001493152-21-003547 Quarter ended 2020-06-302021-02-12acceptance time not in the bulk data set
13F-HR/A 0001493152-21-003354 Quarter ended 2018-09-302021-02-11acceptance time not in the bulk data set
13F-HR/A 0001493152-21-003344 Quarter ended 2017-09-302021-02-11acceptance time not in the bulk data set
13F-HR/A 0001493152-21-003356 Quarter ended 2018-12-312021-02-11acceptance time not in the bulk data set
13F-HR/A 0001493152-21-003348 Quarter ended 2018-03-312021-02-11acceptance time not in the bulk data set
13F-HR/A 0001493152-21-003346 Quarter ended 2017-12-312021-02-11acceptance time not in the bulk data set
13F-HR/A 0001493152-21-003351 Quarter ended 2018-06-302021-02-11acceptance time not in the bulk data set
13F-HR 0001493152-20-021558 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-HR 0001493152-20-015713 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001493152-20-008962 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR/A 0001493152-20-006100 Quarter ended 2019-12-312020-04-09acceptance time not in the bulk data set
13F-HR 0001493152-20-002307 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001493152-19-017317 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001493152-19-012550 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001493152-19-007003 Quarter ended 2019-03-312019-05-14acceptance time not in the bulk data set
13F-HR 0001493152-19-002010 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001493152-18-015951 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001493152-18-011746 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR/A 0001493152-18-011457 Quarter ended 2018-03-312018-08-13acceptance time not in the bulk data set
13F-HR/A 0001493152-18-011455 Quarter ended 2017-12-312018-08-13acceptance time not in the bulk data set
13F-HR/A 0001493152-18-011453 Quarter ended 2017-09-302018-08-13acceptance time not in the bulk data set
13F-HR 0001493152-18-006744 Quarter ended 2018-03-312018-05-14acceptance time not in the bulk data set
13F-HR 0001493152-18-002088 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR/A 0001493152-17-013452 Quarter ended 2017-09-302017-11-17acceptance time not in the bulk data set
13F-HR/A 0001493152-17-013450 Quarter ended 2017-09-302017-11-17acceptance time not in the bulk data set
13F-HR 0001493152-17-013042 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0001493152-17-009084 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001493152-17-005247 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001493152-17-001489 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-HR 0001493152-16-014840 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001493152-16-012350 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR 0001493152-16-009820 Quarter ended 2016-03-312016-05-16acceptance time not in the bulk data set
13F-HR 0001493152-16-007394 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set
13F-HR 0000909012-15-000343 Quarter ended 2015-09-302015-11-16acceptance time not in the bulk data set
13F-HR 0000909012-15-000275 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0000909012-15-000210 Quarter ended 2015-03-312015-05-14acceptance time not in the bulk data set
13F-HR 0000909012-15-000116 Quarter ended 2014-12-312015-02-17acceptance time not in the bulk data set